Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johnathon Liddicoat

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Medical Law Review|May 3, 2026
The promise of the EU's draft repurposing programmeGabriela Lenarczyk, Johnathon Liddicoat
Journal of Law and the Biosciences|October 7, 2021
An empirical study of large, human biobanks: intellectual property policies and financial conditions for accessMatthew Jordan, Johnathon Liddicoat, Kathleen Liddell
Nature Biotechnology|April 8, 2015
Are the gene-patent storm clouds dissipating? A global snapshotJohnathon Liddicoat, Tess Whitton, Dianne Nicol
Nature Biotechnology|November 9, 2016
Myriad's impact on gene patentsMateo Aboy, Kathleen Liddell, Johnathon Liddicoat, et al.
Nature Biotechnology|December 7, 2018
Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?Mateo Aboy, Cristina Crespo, Kathleen Liddell, et al.
Nature Biotechnology|April 14, 2022
European patent protection for medical uses of known products and drug repurposingMateo Aboy, Kathleen Liddell, Matthew Jordan, et al.
Nature Biotechnology|November 10, 2021
Mapping the European patent landscape for medical uses of known productsMateo Aboy, Kathleen Liddell, Johnathon Liddicoat, et al.
Nature Biotechnology|September 13, 2017
After Myriad, what makes a gene patent claim 'markedly different' from nature?Mateo Aboy, Johnathon Liddicoat, Kathleen Liddell, et al.
Nature Biotechnology|May 5, 2019
Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicineMateo Aboy, Cristina Crespo, Kathleen Liddell, et al.
Nature Biotechnology|March 11, 2020
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?Mateo Aboy, Cristina Crespo, Kathleen Liddell, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Medical Law Review|May 3, 2026
The promise of the EU's draft repurposing programmeGabriela Lenarczyk, Johnathon Liddicoat
Journal of Law and the Biosciences|October 7, 2021
An empirical study of large, human biobanks: intellectual property policies and financial conditions for accessMatthew Jordan, Johnathon Liddicoat, Kathleen Liddell
Nature Biotechnology|April 8, 2015
Are the gene-patent storm clouds dissipating? A global snapshotJohnathon Liddicoat, Tess Whitton, Dianne Nicol
Nature Biotechnology|November 9, 2016
Myriad's impact on gene patentsMateo Aboy, Kathleen Liddell, Johnathon Liddicoat, et al.
Nature Biotechnology|December 7, 2018
Was the Myriad decision a 'surgical strike' on isolated DNA patents, or does it have wider impacts?Mateo Aboy, Cristina Crespo, Kathleen Liddell, et al.
Nature Biotechnology|April 14, 2022
European patent protection for medical uses of known products and drug repurposingMateo Aboy, Kathleen Liddell, Matthew Jordan, et al.
Nature Biotechnology|November 10, 2021
Mapping the European patent landscape for medical uses of known productsMateo Aboy, Kathleen Liddell, Johnathon Liddicoat, et al.
Nature Biotechnology|September 13, 2017
After Myriad, what makes a gene patent claim 'markedly different' from nature?Mateo Aboy, Johnathon Liddicoat, Kathleen Liddell, et al.
Nature Biotechnology|May 5, 2019
Mayo's impact on patent applications related to biotechnology, diagnostics and personalized medicineMateo Aboy, Cristina Crespo, Kathleen Liddell, et al.
Nature Biotechnology|March 11, 2020
One year after Vanda, are diagnostics patents transforming into methods of treatment to overcome Mayo-based rejections?Mateo Aboy, Cristina Crespo, Kathleen Liddell, et al.
Pageof 2